Praxis 'Strong Buy': PDUFA In Early 2027 For Ulixacaltamide And BTD Elsunersen

Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.

This buy gives Vertex both a recently-commercialized drug, and a very strong lead candidate.

Prysmian: Hyperscaler Capex Keeps The Buy Case Alive Despite A 300% Rally

Prysmian: Hyperscaler Capex Keeps The Buy Case Alive Despite A 300% Rally

Visa, Mastercard and 140 firms launch Open USD, a stablecoin built to undercut Circle

Aconsortium of more than 140 financial and technology companies, among them Visa, Mastercard, Stripe and Coinbase, launched a new dollar-pegged stablecoin on Tuesday called Open USD. The venture, run by an independent company named Open Standard, is a direct swipe at the economics that have made Circle and Tether the dominant issuers in the sector. [] This story continues at The Next Web

I’ve Never Seen Prime Deals This Good — Here’s What We’re Buying from Caraway, KitchenAid, and More!

This is not a drill. READ MORE...

Ethereum Price Climbs as The Merge and Robinhood Chain Strengthen Network Growth

Ethereum shows recovery after recent market pressure. The price of ethereum is moving above 1,825. The reason behind these prices is thatContinue reading on Coinmonks »

SK hynix ADR listing could attract W7tr in passive inflows: Mirae Asset

SK hynix's plan to begin trading American depositary receipts on the Nasdaq could lift its valuation to a new level, attracting an estimated 7 trillion won (4.5 billion) in passive fund inflows, according to Mirae Asset Global Investments. While SK hynix has long traded at a valuation discount due to its limited access to global investors, an ADR listing would significantly improve its accessibility to US institutional investors and passive funds, Jung Ui-hyeon, head of ETF management at Mira

Sensex today | Stock Market Live Updates: Stock to buy today: Godfrey Phillips India (₹2,281.25)

Sensex, Nifty, Share Prices Live Updates: The stock of Godfrey Phillips India has been on a rise since April after it formed a base at 1,850. Traders can buy now at 2,281 and accumulate at 2,200

Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?

Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US approvals like gFlovent and gVentolin, alongside a rebound in its US business. Domestically, Cipla's performance remains strong, supported by its respiratory portfolio. Citi sees earnings bottoming out and highlights attractive valuations for the Indian market.

Form 144 Crinetics Pharmaceuticals For: 2 July

Form 144 Crinetics Pharmaceuticals For: 2 July

Crude correction next big market trigger: Seksaria

Crude correction next big market trigger: Seksaria

StablecoinX begins Nasdaq trading with $275M ENA treasury after SPAC merger

StablecoinX debuted on Nasdaq under ticker USDE, bringing the first public stablecoin infrastructure company focused on Ethena to U.S. equity markets.

Top Three Videos – July 2, 2026

Larry Lepard: From 2008 to the Coming Reset...Bob Moriarty: Why The Next Two Trading Sessions Are Absolutely Critical For Gold...Jesse Felder: This is the Type of Setup You Look For as an Investor...

Valvoline Coupons and Promo Codes for July 2026

We've gathered all the top Valvoline coupons and promo codes for July 2026, including deals on full synthetic oil changes and other essential maintenance.

AbbVie is buying an eczema and asthma drug developer for nearly $11 billion

The all-cash deal gives AbbVie access to zumilokibart, an experimental drug that could rival Dupixent in treating atopic dermatitis

U.S. Special forces buys Havoc Spear cruise missiles

Leidos received a contract modification worth roughly 27.2 million on behalf of USSOCOM to buy what the military calls All Up Rounds, meaning fully assembled, ready-to-fire missiles rather than components or prototypes, for the AGM-190A Havoc Spear Small Cruise Missile program, with the work centered in Huntsville, Alabama, and expected to run through February 2029. []

European ADRs Climb In Thursday U.S. Morning Session: ARGX, PHIA, CRTO In Focus

European equities traded in the United States as American depositary receipts moved higher during late Thursday morning trading, with several notable movers across the board. argenx SE (NASDAQ: ARGX) stood out as one of the session’s stronger performers, with its ADR posting a gain of 4.43 during the late morning period. Koninklijke Philips N.V. (NASDAQ: [] The post European ADRs Climb In Thursday U.S. Morning Session: ARGX, PHIA, CRTO In Focus appeared first on Foreign Policy Journal.